Log in or Sign up for Free to view tailored content for your specialty!
Geriatrics News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
The CMS finalized cuts to the 2025 physician fee schedule for the fifth year in a row, prompting an urgent call-to-action from the American Academy of Dermatology. HHS, through the CMS, announced the finalization of the 2025 Medicare Physician Fee Schedule.
Top news of July: Permanent makeup, FDA approvals, tattoos, more
Healio has compiled July’s most-read news in dermatology.
Top news of June: Cancer risk, leaf extract, fungal infections, more
Healio has compiled June’s most-read news in dermatology.
Log in or Sign up for Free to view tailored content for your specialty!
Top news of April: Product rankings, counterfit Botox, solar eclipse
Healio has compiled April’s most-read news in dermatology.
Actinic keratosis incidence rates remain high in older populations
Actinic keratosis remains a public health problem for older adults, occurring in approximately three of every 10 Medicare recipients, according to a research letter published in JAMA Dermatology.
Nomacopan well tolerated in bullous pemphigoid treatment
Nomacopan was well tolerated and beneficial in patients with bullous pemphigoid, according to phase 2a clinical trial results.
Researchers organize bullous pemphigoid by three main profiles
Researchers identified three different clusters of bullous pemphigoid, the most common autoimmune blistering disorder, according to a study published in the Journal of American Academy of Dermatology.
Findings shed light on humoral response in gliptin-associated bullous pemphigoid
The humoral response to BP180 and BP230 antigens is weakened in certain patients with gliptin-associated bullous pemphigoid, according to a study.
Bullous pemphigoid increases cardiovascular disease mortality risk
Patients with bullous pemphigoid experienced increases in cardiovascular mortality risk at 1, 3 and 5 years compared with matched controls, according to a study.
Worldwide mortality rate high for bullous pemphigoid
A multi-continental meta-analysis showed high mortality rates for patients with bullous pemphigoid.
-
Headline News
Medicare selects 15 drugs for second round of price negotiations, including semaglutide
January 17, 20252 min read -
Headline News
Q&A: Physicians can help patients with respiratory diseases prepare for wildfires
January 17, 20253 min read -
Headline News
‘Now is not the time to lose momentum’ in the fight against STIs
January 10, 20259 min read
-
Headline News
Medicare selects 15 drugs for second round of price negotiations, including semaglutide
January 17, 20252 min read -
Headline News
Q&A: Physicians can help patients with respiratory diseases prepare for wildfires
January 17, 20253 min read -
Headline News
‘Now is not the time to lose momentum’ in the fight against STIs
January 10, 20259 min read